FDA frontier model eval risks capture by first mover, warns Anka Reuel
AnkaReuel · x · 2026-09-19
Anka Reuel highlights a structural risk in an FDA frontier-model evaluation case: evaluator Accenture lacks sufficient domain expertise and must rely on Anthropic, the company being evaluated — so eval criteria risk being shaped by the first mover. The quoted reply warns Anthropic may effectively help write the evaluation protocols, a known issue in bio/medtech. Reuel calls on Accenture to publish a frontier-model evaluation for independent expert scrutiny, both to prove competence and to improve its process.
More from Companies & People
- Harvard's free ML Systems textbook (CS249r) hits 29.8K GitHub stars — techNmak · 2026-11-04
- Keith Rabois mocked as old tweets resurface: he said "Stripe is going nowhere" and predicted Quora would be the most valuable post-2005 company — zeeg · 2026-11-04
- Apple warns investors of 'unpredictable' autonomous AI agent risks — unconventionalbook · 2026-11-04
- Three Claude Code Core Members Leave Anthropic Within 10 Days Ahead of Potential IPO — haider1 · 2026-11-04
- 2012 tribute: when few believed in deep learning, Andrew Ng was the beacon — Kuprel · 2026-11-04
- Google DeepMind is hiring engineers to build AI Studio and the Gemini API — AI_Andrew · 2026-11-04